TalkMed Group Limited 5G3.SI Stock
TalkMed Group Limited Price Chart
TalkMed Group Limited 5G3.SI Financial and Trading Overview
| TalkMed Group Limited stock price | 0.43 SGD |
| Previous Close | 0.42 SGD |
| Open | 0.41 SGD |
| Bid | 0.42 SGD x 0 |
| Ask | 0.42 SGD x 0 |
| Day's Range | 0.41 - 0.42 SGD |
| 52 Week Range | 0.38 - 0.44 SGD |
| Volume | 25K SGD |
| Avg. Volume | 10.89K SGD |
| Market Cap | 549.67M SGD |
| Beta (5Y Monthly) | 0.211877 |
| PE Ratio (TTM) | 20.75 |
| EPS (TTM) | 0.02 SGD |
| Forward Dividend & Yield | 0.03 (7.23%) |
| Ex-Dividend Date | April 28, 2023 |
| 1y Target Est | N/A |
5G3.SI Valuation Measures
| Enterprise Value | 471.35M SGD |
| Trailing P/E | 20.75 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.1758156 |
| Price/Book (mrq) | 6.19403 |
| Enterprise Value/Revenue | 6.153 |
| Enterprise Value/EBITDA | 12.018 |
Trading Information
TalkMed Group Limited Stock Price History
| Beta (5Y Monthly) | 0.211877 |
| 52-Week Change | 7.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.44 SGD |
| 52 Week Low | 0.38 SGD |
| 50-Day Moving Average | 0.42 SGD |
| 200-Day Moving Average | 0.41 SGD |
5G3.SI Share Statistics
| Avg. Volume (3 month) | 10.89K SGD |
| Avg. Daily Volume (10-Days) | 11.56K SGD |
| Shares Outstanding | 1.32B |
| Float | 186.9M |
| Short Ratio | N/A |
| % Held by Insiders | 85.59% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 7.22% |
| 5 Year Average Dividend Yield | 442.00% |
| Payout Ratio | 1.0435 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 39.87% |
| Operating Margin (ttm) | 50.52% |
| Gross Margin | 61.31% |
| EBITDA Margin | 51.20% |
Management Effectiveness
| Return on Assets (ttm) | 22.19% |
| Return on Equity (ttm) | 33.70% |
Income Statement
| Revenue (ttm) | 76.6M SGD |
| Revenue Per Share (ttm) | 0.06 SGD |
| Quarterly Revenue Growth (yoy) | 38.39% |
| Gross Profit (ttm) | 47.16M SGD |
| EBITDA | 39.22M SGD |
| Net Income Avi to Common (ttm) | 30.55M SGD |
| Diluted EPS (ttm) | 0.02 |
| Quarterly Earnings Growth (yoy) | 28.69% |
Balance Sheet
| Total Cash (mrq) | 81.24M SGD |
| Total Cash Per Share (mrq) | 0.06 SGD |
| Total Debt (mrq) | 7.09M SGD |
| Total Debt/Equity (mrq) | 8.38 SGD |
| Current Ratio (mrq) | 4.89 |
| Book Value Per Share (mrq) | 0.067 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 37.29M SGD |
| Levered Free Cash Flow (ttm) | 28.77M SGD |
Profile of TalkMed Group Limited
| Country | Singapore |
| State | N/A |
| City | Singapore |
| Address | 3 Mount Elizabeth |
| ZIP | 228510 |
| Phone | N/A |
| Website | https://www.talkmed.com.sg |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 206 |
TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, and palliative care services in Singapore, China, Hong Kong, Vietnam, India, Australia, and internationally. It operates through three segments: Oncology Services; Stem Cell Related Products and Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignancies and brain cancers, as well as lymphoma and leukaemia. It also provides palliative care services comprising cancer pain management, discharge and home care planning, advance care planning, and end-of-life care planning; and ancillary health services, such as CANSCREEN, a screening program that provides screening for individuals at a risk of getting cancer. In addition, the company is involved in the goods and services related to cellular and gene therapy; specialist doctors and clinical staff services; and healthcare management services. It operates a network of nine clinics. The company was founded in 1997 and is based in Singapore. TalkMed Group Limited is a subsidiary of Ladyhill Holdings Pte. Ltd.
Q&A For TalkMed Group Limited Stock
What is a current 5G3.SI stock price?
TalkMed Group Limited 5G3.SI stock price today per share is 0.43 SGD.
How to purchase TalkMed Group Limited stock?
You can buy 5G3.SI shares on the SES exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TalkMed Group Limited?
The stock symbol or ticker of TalkMed Group Limited is 5G3.SI.
Which industry does the TalkMed Group Limited company belong to?
The TalkMed Group Limited industry is Medical Care Facilities.
How many shares does TalkMed Group Limited have in circulation?
The max supply of TalkMed Group Limited shares is 1.33B.
What is TalkMed Group Limited Price to Earnings Ratio (PE Ratio)?
TalkMed Group Limited PE Ratio is 21.25000200 now.
What was TalkMed Group Limited earnings per share over the trailing 12 months (TTM)?
TalkMed Group Limited EPS is 0.02 SGD over the trailing 12 months.
Which sector does the TalkMed Group Limited company belong to?
The TalkMed Group Limited sector is Healthcare.